Private Debt Interview Questions: Complete Q&A Guide 2026

This is a structured Q&A bible for private debt and direct lending interviews — 50+ questions with full model answers, organized so you can drill by topic. Use it to go deep on credit fundamentals, deal structuring, credit analysis in practice, market dynamics, and fit questions. This guide is designed to be worked through actively: read the question, formulate your answer, then read the model answer to identify gaps.

Section 1: Credit Fundamentals (15 questions)

Q1. What is the difference between leverage and coverage?

Leverage measures the size of debt relative to income — how much debt has been taken on. The most common metric is Total Debt / EBITDA (or Net Debt / EBITDA). Leverage tells you the magnitude of the obligation.

Coverage measures the company's ability to service that debt from operating cash flow — EBITDA / Interest (interest coverage) or (EBITDA − CapEx) / (Interest + Principal) (fixed charge coverage). Coverage tells you the margin of safety between income and obligation.

Both matter. A company can have low leverage (3× net debt/EBITDA) but low coverage (1.1× interest coverage) if it has high CapEx or taxes. Conversely, high leverage (6×) can be manageable if cash interest coverage is 3× in a stable business.

Q2. Walk me through the 5 credit ratios you always calculate first.

Always compute these in base case and downside case. The gap between them under stress tells you the covenant headroom and likelihood of breach.

Q3. How do you define Free Cash Flow in a credit context?

In credit analysis, FCF = EBITDA − CapEx − Cash Taxes − Cash Interest − Required Debt Amortization ± Working Capital Changes. This is the cash actually available after meeting all obligations — what's left for optional debt repayment, dividends, or liquidity buffer.

A key nuance: always distinguish between maintenance CapEx (required to keep business running) and growth CapEx (discretionary). In a stress scenario, the company can cut growth CapEx but must maintain maintenance CapEx — so use maintenance CapEx in your downside FCF.

Q4. What is EBITDA and why do lenders care so much about its definition?

EBITDA = Earnings Before Interest, Taxes, Depreciation, and Amortization. It's used as a proxy for operating cash flow and is the denominator in leverage and coverage ratios — so its definition determines whether covenants breach.

The devil is in the "addbacks." Borrowers and sponsors negotiate to add back: management fees, restructuring charges, pro-forma synergies from acquisitions, non-recurring items, and stock-based compensation. Aggressive addbacks inflate EBITDA, reducing reported leverage and creating an illusion of more headroom than actually exists. Lenders scrutinize addbacks because a company with $40M "EBITDA" including $12M of addbacks actually has $28M in real cash-generating earnings.

Q5. What are the main credit risk components you assess in a deal?

The 5 C's provide a clean framework:

• Character: Management quality, sponsor track record, governance, willingness to support the business
• Capacity: Cash flow generation — leverage, coverage, FCF conversion over the cycle
• Capital: Equity cushion; how much sponsor equity is at risk ahead of lenders
• Collateral: Security package — what can lenders seize? What is it worth in stress?
• Conditions / Covenants: Contract terms that protect lenders and macro/sector dynamics

Q6. What makes a business "lender-friendly"?

A lender-friendly business has: (1) Recurring, visible revenues — subscription, long-term contract, or essential services; (2) Defensive end markets — not highly cyclical or correlated with economic downturns; (3) High FCF conversion — low CapEx requirements relative to EBITDA; (4) Strong equity cushion — sponsor has significant equity invested below the debt; (5) Pricing power — can maintain margins under input cost pressure; (6) Low customer concentration — no single customer >20% of revenue.

Q7. How do you calculate covenant headroom?

Always express headroom in both ratio terms (e.g., "1× of cushion") and EBITDA decline terms ("EBITDA must fall 17% to breach"). The latter is more intuitive in stress discussions.

Q8. What is the difference between business risk and financial risk?

Business risk is the risk inherent in the company's operations — market demand, competitive dynamics, customer concentration, pricing power, operating leverage (fixed vs. variable costs). A cyclical manufacturer has high business risk; a software-as-a-service business has lower business risk.

Financial risk is the risk from the capital structure — how much debt, at what cost, with what maturity profile. Same business risk, different financial risk depending on leverage.

The key lender insight: high business risk should be paired with lower financial risk (less leverage, more covenants). Lenders accept more financial risk when business risk is low. Mismatch (high business risk + high leverage) is a red flag.

Q9. What red flags do you look for in working capital?

Working capital red flags: (1) Deteriorating DSO (days sales outstanding) — customers paying slower, may signal collection problems or relationship deterioration; (2) Rising inventory — possible demand slowdown or obsolescence; (3) Declining DPO(days payable outstanding) — paying suppliers faster, may signal credit terms tightening; (4) Large one-time working capital release in the reporting period — overstates FCF, may reverse; (5) Mismatch between revenue growth and working capital — if revenue grows fast but WC doesn't expand proportionally, could indicate channel stuffing.

Q10. How do you think about liquidity vs. solvency risk?

Liquidity risk: the company runs out of cash to pay obligations in the short term — even if it's solvent long-term. Caused by: negative seasonal FCF, a large debt maturity, or a sudden covenant breach requiring immediate repayment. Monitor: cash balance + revolver availability vs. near-term uses (interest, scheduled amortization, working capital peak).

Solvency risk: the total enterprise value is less than total debt — the company is worth less than it owes. This is the ultimate credit failure.

In practice, liquidity kills faster — a solvent company can go bankrupt for lack of cash. This is why lenders require revolving credit facilities and monitor liquidity covenants closely.

Q11. What is operating leverage and why does it matter in credit analysis?

Operating leverage = the sensitivity of EBITDA to revenue changes, driven by the fixed vs. variable cost structure. High fixed costs = high operating leverage: a 10% revenue decline causes a 25–30% EBITDA decline if costs don't fall proportionally. Low fixed costs = low operating leverage: revenue drops flow through more proportionally.

For lenders, high operating leverage is a risk amplifier. In a downside scenario, EBITDA can deteriorate much faster than revenue — collapsing coverage ratios and blowing through covenants. The stress case for a high-operating-leverage business must model EBITDA erosion more aggressively than a simple revenue haircut.

Q12. How do you analyze customer concentration risk?

Ask: what % of revenue comes from the top 5 customers? What are the contract terms (length, renewability, exclusivity)? What switching costs exist? What is the customer's own financial strength?

Rule of thumb: if a single customer exceeds 10–15% of revenue, that's a flag — require covenant language (cash sweep or prepayment trigger if major customer contract is not renewed). If one customer is 40%+ of revenue, the credit analysis must underwrite the loss of that customer as a credible downside.

Q13. What is CapEx intensity and how does it affect your credit analysis?

CapEx intensity = CapEx / Revenue (or CapEx / EBITDA). High CapEx intensity reduces FCF conversion — a company with 25% EBITDA margin but 15% CapEx/revenue has very limited free cash flow. This is critical for lenders because debt service comes from FCF, not EBITDA. A maintenance-heavy business (utilities, industrial manufacturing) requires explicit modeling of capex cycles and potential spikes.

Q14. How do you assess management quality in a credit context?

Track record: has this team managed through a downturn? Did they communicate transparently with lenders? Did they protect the business operationally? Skin in the game: does management own equity or options that align them with preserving business value (not just growing it)? Sponsor quality: for sponsor-backed deals, what is the sponsor's reputation for supporting portfolio companies vs. extracting value? Have they ever done dividend recaps right before a default? These are all fair due diligence questions.

Q15. What is enterprise value (EV) and why does it matter as a lender?

EV is the total value of the business — what you'd pay to own it outright (equity + net debt). As a lender, EV matters because it determines your recovery in a restructuring: if EV is $100M and debt is $80M, lenders are likely to recover close to par. If EV is $100M and debt is $200M, lenders take impairment. Quick rule: if the company is trading at or below 1× leverage (EV/EBITDA < 1×), something is wrong. The key question is: at what EV level does the debt become impaired?

Section 2: Deal Structuring (12 questions)

Q16. How is a direct lending loan priced?

Pricing = Reference Rate (SOFR) + Credit Spread + OID (Original Issue Discount). In 2025–2026: mid-market deals typically price at SOFR + 450–600 bps; large-cap direct lending (>$1B) has compressed to SOFR + 350–450 bps. OID of 50–150 bps adds to lender yield. The all-in yield for a mid-market loan at SOFR 5.30% + 500 bps + 1 pt OID amortized over 3 years = approximately 11%. Lenders also earn arrangement fees (typically 1–2%) upfront.

Q17. What is OID (Original Issue Discount) and how does it affect lender yield?

OID means the loan is issued at less than par — e.g., a $100M loan issued at 99 OID means the borrower receives $99M but owes $100M at maturity. The $1M discount is additional yield for the lender. It also serves as soft call protection — the borrower can't refinance at par immediately because OID is already earned by lenders. On a 3-year average life, 100 bps of OID ≈ 33 bps of additional annual yield.

Q18. What is PIK (Payment-In-Kind) interest?

PIK interest is added to the principal rather than paid in cash. Example: $100M loan at 10% with PIK toggle — instead of paying $10M interest, the borrower adds $10M to the principal, which is now $110M and accrues interest next year. PIK preserves borrower cash flow short-term but increases total debt — the compounding effect can rapidly increase leverage. Lenders accept PIK for: (1) situations where the business needs cash preservation, (2) junior/mezz capital where PIK is built into the yield structure, (3) sponsor-backed deals where the sponsor is confident in a near-term exit. Risk: if the PIK compounds for too long, the debt becomes unmanageable.

Q19. What is a unitranche facility?

Unitranche is a single blended loan to the borrower that combines first-lien and second-lien risk into one instrument. From the borrower's perspective: one lender group, one set of docs, one all-in rate. Behind the scenes, lenders can split economics and control rights via an Agreement Among Lenders (AAL) — dividing into "first-out" (lower risk, lower yield, senior in enforcement) and "last-out" (higher risk, higher yield, subordinated). Typical pricing: blended rate between a first-lien rate and a second-lien rate. Unitranche has become the dominant structure for mid-market sponsor-backed transactions — $210B+ in middle-market issuance was reported in 2024.

Q20. What is the difference between first lien and second lien debt?

First lien: senior secured, first priority over collateral in any enforcement. In a default, first lien lenders get paid before anyone else. Lower yield (compensated by priority).
Second lien: also secured, but subordinated to first lien — they get paid only after first lien is fully recovered. Higher yield (compensated by subordination risk). In a restructuring, second lien lenders often recover less than par; in some cases, they receive equity or subordinated paper. For the borrower, second lien allows higher total leverage than first lien alone.

Q21. What is a super senior revolving credit facility (RCF)?

The super senior RCF sits at the top of the capital structure — above even first-lien term loans. It's a revolving facility (can be drawn and repaid multiple times) providing liquidity for working capital and general corporate purposes. "Super senior" means it has priority over all other creditors in enforcement. In unitranche deals, a bank RCF is often super senior to provide cost- effective liquidity (banks price revolvers cheaply relative to direct lenders). The direct lender accepts subordination of their term loan because the revolver usage is limited and they receive a fee for consenting to it.

Q22. What is a maintenance covenant and how does it work?

A maintenance covenant is a financial test that must be met periodically (typically quarterly). Example: "Total Leverage Ratio shall not exceed 6.0× as of the last day of each fiscal quarter." If the company's actual leverage exceeds 6.0× at any quarterly test date, it's an event of default (unless waived or cured). Maintenance covenants give lenders an early warning mechanism — deterioration in the business triggers covenants before a payment default, giving lenders leverage to renegotiate, get additional security, or force management change.

Q23. What is an incurrence covenant?

An incurrence covenant is only tested when the borrower takes a specific action — like incurring new debt, making an acquisition, paying dividends, or selling assets. Example: "The borrower may not incur additional debt unless pro-forma leverage is below 5.5×." If leverage is already 5.5×, the borrower is blocked from adding more debt — but there's no periodic test. Incurrence covenants protect against specific actions but provide less early warning than maintenance covenants. Covenant-lite structures (common in broadly syndicated loans, increasingly in large-cap private credit) rely primarily on incurrence covenants.

Q24. What are EBITDA addbacks and why do they create credit risk?

EBITDA addbacks are items added to reported EBITDA to arrive at "covenant EBITDA" or "adjusted EBITDA." Common addbacks: management fees, restructuring and transaction costs, cost savings and synergies expected but not yet realized ("run-rate" synergies), non-cash items, stock compensation. The risk: addbacks inflate EBITDA, making leverage look lower than it really is. A 5× leverage based on heavily adjusted EBITDA might be 7× leverage on actual cash EBITDA. Lenders must scrutinize addbacks during underwriting — especially "pro-forma" synergies from acquisitions that may not materialize.

Q25. What is the security package in a direct lending deal?

Security package = the collateral pledged by the borrower to secure the loan. Typical for a sponsor-backed direct loan: (1) first-priority lien on all assets (accounts receivable, inventory, PP&E, intellectual property); (2) pledge of equity in the borrower and all material subsidiaries; (3) guarantees from material subsidiaries. The quality of the security package determines recovery if the company defaults. Asset-heavy businesses (manufacturing, real estate) have tangible collateral; asset-light businesses (software, services) have limited tangible collateral — the equity value of the business is the main source of recovery.

Q26. What covenants would you require for a cyclical business?

For a cyclical business (manufacturing, construction, automotive supplier), I'd require: (1) Tight maintenance leverage covenant with conservative headroom — test quarterly so any EBITDA decline is caught early; (2) Liquidity covenant — minimum cash + revolver availability; cyclicals need buffers during trough; (3) CapEx covenant — limit discretionary capex so cash is conserved in downturns; (4) Dividend restriction— no distributions unless coverage exceeds X×; (5) Reporting — monthly financials (not just quarterly) so I can track deterioration in real time.

Q27. What is a restricted payment basket?

A restricted payment basket governs how much cash the borrower can send to its equity holders (dividends, management fees, intercompany loans to non-guarantor entities). Lenders restrict payments to prevent the borrower from extracting value to the detriment of lenders — essentially a "leakage" control. A typical basket: "restricted payments are permitted if (a) no default exists and (b) pro-forma leverage is below X× after giving effect to the payment." If a sponsor does a dividend recap without complying with this basket, it's an event of default.

Section 3: Credit Analysis in Practice (10 questions)

Q28. How do you size debt for a leveraged buyout?

Debt sizing in LBO lending starts with DSCR and leverage constraints: (1) Determine the maximum leverage the business can support — typically 5–6× for stable businesses, 3–4× for cyclicals. (2) Check coverage: at maximum leverage, does EBITDA / Interest exceed 2.0× in base case and 1.3× in downside? (3) Check FCF for debt amortization: can the company service mandatory amortization (typically 1% per year for term loans)? (4) Check covenant headroom: at close, is there 20–25% headroom to maintenance covenant levels?

Q29. How do you build a downside case?

A good downside case is not "revenue down 10%." It is a coherent story of what could go wrong and why: (1) Identify the key risk: pricing pressure from a new competitor; loss of a major customer; margin compression from input costs. (2) Quantify the impact: revenue −15%, EBITDA margin −200 bps due to operating leverage → EBITDA down ~25%. (3) Model through the debt schedule: what happens to coverage? Does covenant breach? Does FCF turn negative? (4) Check liquidity: can the company survive 12–18 months of stress on available cash + revolver? (5) Recovery analysis: if EV contracts to 5×–6× distressed EBITDA, where do lenders stand in the capital structure?

Q30. What is recovery analysis and how do you do it quickly?

Recovery analysis estimates what lenders would receive in a restructuring or liquidation. Quick approach: (1) Going concern EV: stressed EBITDA × stressed multiple (typically 4–6× for a distressed business — below market because buyers demand discount for distress). (2) Cap EV at face value of claims above you. (3) If going concern EV exceeds your debt: full recovery. If not, model pro-rata recovery based on where value breaks in the capital structure. Quick rule: if EV/EBITDA in a stress case is 5× and leverage at close is 5×, there's almost no equity cushion — lenders are at the money.

Q31. How do you think about sector cyclicality in credit underwriting?

Cyclical sectors (auto, chemicals, building materials) require through-the-cycle underwriting — don't lend based on peak EBITDA. Use mid-cycle EBITDA (average over a full business cycle, often 5–7 years of history). Size leverage based on mid-cycle, not peak. Build in a downside that reflects a genuine trough scenario (e.g., 2008–2009 auto volumes, not just a mild slowdown). Defensive sectors (healthcare services, essential software, food distribution) allow slightly more leverage because downside EBITDA is more predictable.

Q32. What are early warning signs in portfolio monitoring?

Monthly/quarterly: (1) Revenue below plan with no explanation; (2) EBITDA margin compression; (3) Free cash flow negative or declining; (4) Working capital deteriorating (rising DSO, declining DPO); (5) Revolver draw increasing without clear seasonal reason; (6) Management changes (especially CFO departure — a red flag for financial reporting issues); (7) Sponsor going quiet on communications; (8) Third-party contracts (major customers) not renewed; (9) Covenant headroom declining quarter over quarter; (10) External data: Google Maps reviews dropping, job postings declining, supplier payments being stretched.

Q33. How do you handle a covenant breach?

A covenant breach is an event of default — lenders have remedies including acceleration (demand repayment) and enforcement (take security). In practice, most covenant breaches are resolved via a waiver or amendment: lenders grant the borrower time to cure or negotiate amended covenant levels. In exchange, lenders typically receive: amendment fee, tighter covenant levels or additional covenants, potentially additional security or equity cures. The key question: is this a liquidity crisis or a solvency crisis? If solvency (EV below debt), no amendment helps — you need restructuring. If liquidity (short-term cash shortfall), an amendment may buy time for operational recovery.

Q34. What is an equity cure?

An equity cure is a provision allowing the sponsor to inject equity to cure a covenant breach. If leverage is 6.5× against a 6.0× covenant, the sponsor can inject enough equity to pay down debt (or be added to EBITDA, depending on the cure mechanism) to bring the ratio back into compliance. Equity cures are typically limited (max 2–3 times per loan life, and only certain number per rolling period) to prevent sponsors from repeatedly delaying real resolution of a deteriorating situation. As a lender, you want equity cures because they bring additional capital — but you also don't want endless cures masking a fundamentally broken business.

Q35. How do you analyze a PE sponsor-backed deal differently from a non-sponsored deal?

Sponsored deals have advantages: (1) Sponsors have equity at risk below the debt — they're incentivized to support the business; (2) Sponsors can inject capital (equity cure) if needed; (3) Sponsor-operated companies often have better reporting, governance, and management professionalism. The risks: (1) Sponsors may dividend recap equity if the business performs well — draining cash ahead of lenders; (2) Sponsor bias toward equity maximization can conflict with lender interest (e.g., growth capex that elevates leverage vs. debt paydown); (3) Sponsor relationships can cause lenders to be too accommodating in amendments. Always assess the specific sponsor's track record, not just the generic "sponsor-backed" label.

Q36. What is refinancing risk and how do you manage it?

Refinancing risk = the risk that when the loan matures, the borrower cannot refinance on acceptable terms (or at all). Causes: (1) Credit markets have tightened (spreads wider, risk appetite lower); (2) Company has deteriorated and would face much worse terms; (3) PIK interest has compounded, making the debt load unmanageable. Mitigation: (1) Ensure sufficient maturity runway at close (5–7 years); (2) Negotiate no "maturity wall" on revolvers before the term loan (revolver maturity should follow term loan); (3) Build in PIK limits so compounding doesn't create runaway leverage; (4) Monitor credit market conditions and refinance proactively if the company is performing.

Q37. How do you model a leveraged buyout from a lender's perspective?

Lender's LBO model differs from the PE model in focus: (1) Debt sizing: compute maximum debt at close consistent with DSCR and leverage constraints; (2) Base case: project EBITDA conservatively; model interest (floating rate — use forward curve), mandatory amortization, and revolver usage; (3) Downside case: stress EBITDA −20–30%, model coverage ratios, check covenant headroom, assess liquidity; (4) Recovery analysis: compute EV in stressed scenario and recovery to each tranche; (5) Conclusion: can we underwrite this debt with high confidence of repayment even in downside? Not: what is the equity IRR?

Section 4: Market & Industry (8 questions)

Q38. What is the difference between direct lending and broadly syndicated loans (BSL)?

Q39. What is a BDC (Business Development Company)?

A BDC is a public company (listed on a US stock exchange) that provides financing to private middle- market companies. BDCs are regulated investment companies — they must distribute 90%+ of taxable income as dividends and are required to maintain certain diversification standards. They borrow at investment-grade rates and lend to below-investment-grade middle-market companies, capturing the spread as income. Large BDC platforms include Ares Capital Corporation (the largest publicly traded BDC, ~$23B+ in investments), Blue Owl Capital Corporation, and Golub Capital BDC. BDCs allow retail and institutional investors to access private credit returns with liquidity.

Q40. How does private credit compare to public leveraged credit (high yield bonds, leveraged loans)?

Private credit offers: higher yield (SOFR + 450–600 bps vs. SOFR + 250–400 bps for BSL); tighter covenants and information rights; customized terms. Tradeoff: illiquidity (can't sell the loan), less diversification, less transparency. JP Morgan data shows direct lending annualized returns of approximately 9% vs. leveraged loans at ~5.5% as of early 2026 — a meaningful premium that compensates for illiquidity. The gap has narrowed as private credit has grown and competition has intensified.

Q41. What happened to private credit spreads in 2024–2025 and why?

Spreads compressed significantly. In 2022–2023, mid-market unitranche deals priced at SOFR + 600–700 bps. By 2025–2026, quality borrowers access SOFR + 450–550 bps, and large-cap direct lending has approached SOFR + 350–450 bps. Causes: (1) Too much capital chasing too few quality deals — AUM of private credit grew from ~$1.3T in 2021 to $2.2T+ in 2025; (2) Sponsor leverage: sponsors play lenders against each other; (3) Large-cap expansion has commoditized the biggest deals. This is a live interview topic — you should be able to discuss what spread compression means for underwriting standards and return expectations.

Q42. What is asset-based finance (ABF) and how has it grown in private credit?

ABF is lending secured by pools of financial assets — receivables, consumer loans, mortgages, equipment leases, royalty streams — rather than corporate enterprise value. It's been the fastest-growing segment of private credit: banks pulling back from consumer and specialty lending has created opportunities for credit funds. Examples: lending to a fintech company secured by its consumer loan portfolio; purchasing trade receivables from a large manufacturer; equipment financing for logistics companies. ABF requires different analytical skills — loan tape analysis, default rate modeling, pool-level diversification — compared to leveraged finance.

Q43. What is the role of CLOs in the leveraged credit ecosystem?

CLOs (Collateralized Loan Obligations) are structured vehicles that buy leveraged loans, bundle them, and issue tranched securities with different risk/return profiles (AAA, AA, A, BBB, BB, equity). They are the largest buyers of broadly syndicated leveraged loans — approximately 65–70% of BSL volume is purchased by CLOs. CLOs provide significant liquidity to the leveraged loan market. When CLO issuance is strong (as in 2024–2025), loan markets are liquid and spreads compress; when CLO issuance contracts, liquidity dries and spreads widen. Private credit funds increasingly compete with CLOs for middle-market loans.

Q44. How do you think about the regulatory environment for private credit?

The BIS and FSB have flagged private credit as a systemic concern — opacity, leverage, and interconnectedness with banks. Key regulatory risks: (1) Leverage limits: if regulators impose limits on fund leverage, financing costs and returns change; (2) Reporting requirements: more disclosure on underlying loan quality; (3) Insurance capital rules: many private credit funds raise capital from insurance companies (Blackstone Credit, Apollo) — changes to insurance regulatory capital treatment could affect demand; (4) Bank interconnectedness: banks provide NAV facilities and subscription credit lines to private credit funds — regulatory changes to bank exposure to private credit affect fund leverage. Being aware of these concerns signals sophisticated understanding of the asset class.

Q45. What is the difference between direct lending and special situations?

Direct lending / core private credit: lending to performing businesses, typically sponsor-backed, stable EBITDA, underwriting based on going-concern cash flows. Goal: earn contractual yield with high certainty.
Special situations: lending to stressed, distressed, or complex situations — businesses with operational issues, covenant breaches, sector distress, or complex capital structures. Requires restructuring and recovery analysis skills. Higher return potential (15–20%+) with higher risk and complexity. Analytical skillset is different: less about underwriting stable cash flows, more about navigating defaults, amendments, DIP financing, and recovery maximization.

Section 5: Fit & Motivation (5 questions)

Q46. Why credit rather than equity?

A strong answer should be genuine and specific. Avoid "I like the downside protection" without context. Better: "I find credit analysis compelling because it requires a different mental model than equity — I'm evaluating the distribution of outcomes from the lender's perspective, not the most likely case. What I enjoy is identifying and structuring against downside scenarios: what are the three ways this business can impair our principal, and how do we structure to protect against each? The credit discipline — covenants, security, coverage — gives me tools to manage risk in ways that equity investing doesn't. I also find the direct relationship with management in private credit (as a bilateral or small-group lender) more intellectually engaging than being one of 100 holders in a syndicated loan."

Q47. Why direct lending and not high yield or leveraged loans?

Three honest reasons: (1) Relationship and control — in direct lending, you negotiate terms directly, maintain an ongoing lender-borrower relationship, and have governance rights. In traded markets, you're a price-taker. (2) Covenant quality — direct lenders typically get maintenance covenants and better information rights vs. covenant-lite BSL. (3) Return premium — direct lending earns 100–250 bps more than equivalent BSL for the same credit risk, compensating for illiquidity and complexity. The intellectual satisfaction of doing original credit analysis (vs. trading secondary prices) also matters.

Q48. What makes a good private credit investor?

The best credit investors share: (1) Skepticism — they naturally ask "what could go wrong?" before "what could go right?"; (2) Structuring creativity — they can craft terms that protect downside while still closing the deal; (3) Discipline — the ability to say no to a deal that looks attractive on headline metrics but fails downside analysis; (4) Portfolio management mindset — individual position risk combined with concentration and correlation risk at the portfolio level; (5) Communication clarity— can explain the credit story to an IC in 2 minutes with a clear recommendation.

Q49. Where do you see private credit in 5 years?

Private credit will continue to grow, but likely at a slower pace as: (1) Spreads have compressed and returns are less clearly superior to public markets; (2) More regulatory scrutiny will require better disclosure; (3) The asset class will bifurcate further — commodity direct lending (large-cap, SOFR + 350) vs. specialist credit (complex situations, ABF, specialty finance) where true skill generates alpha. The largest platforms (Ares, HPS, Apollo, Blue Owl) will continue to scale with insurance capital; smaller specialist managers will outperform on skill. The most interesting careers will be in the specialist credit space rather than vanilla direct lending.

Q50. Tell me about a deal you would have passed on (and why).

Strong answers: cite a real public situation (avoid inventing deals). Example structure: "I would have passed on lending to [X type of business] during [period] because: (1) the leverage was being sized on peak-cycle EBITDA with a meaningful addback for 'synergies' that hadn't been realized; (2) the sponsor had a track record of dividend recaps right before performance deteriorated; (3) the sector (e.g., COVID-sensitive hospitality) had visible demand risk that the model didn't adequately stress. The 5× reported leverage was probably 7× on real cash EBITDA, with coverage that would have broken in any modest revenue decline." Show that you could recognize the warning signs.

Quick reference: numbers and benchmarks to know

Key takeaways

Related Resources

• Breaking Into Private Debt (2026): Complete Career Guide — Full career guide, deal anatomy, and 30-day prep plan
• LBO Interview Questions: Ultimate Guide — Understanding sponsor context and leverage dynamics
• How the 3 Financial Statements Link Together — Build the accounting foundation for credit analysis
• Walk Me Through a DCF — Valuation methodology for enterprise value and recovery analysis